Role of Na+/H+ exchanger in the pathogenesis of ischemic acute renal failure in mice

Journal of Cardiovascular Pharmacology

Volumn 49, Issue 3, 2007, Pages 154-160

  Yamashita, Junji ^a,b   Ohkita, Mamoru ^a   Takaoka, Masanori ^a   Kaneshiro, Yoshiaki ^b   Matsuo, Takato ^b   Kaneko, Kenji ^b   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Pharmaceutical Company   (Japan)

Author keywords

Acute renal failure; EIPA; Endothelin 1; Ischemia reperfusion; Na+ H+ exchange; Renal function

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; ENDOTHELIN 1; SODIUM PROTON EXCHANGE PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; FUNCTIONAL PROTEOMICS; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; KIDNEY DYSFUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE EPITHELIUM; KIDNEY TUBULE NECROSIS; KIDNEY VEIN; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RENAL ARTERY; RENAL PROTECTION; REPERFUSION; REPERFUSION INJURY;

AMILORIDE; ANIMALS; ENDOTHELIN-1; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY TUBULAR NECROSIS, ACUTE; KIDNEY TUBULES; MALE; MICE; PROTECTIVE AGENTS; REPERFUSION INJURY; SODIUM-HYDROGEN ANTIPORTER;

EID: 34147217079     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318030c2c9     Document Type: Article

References (27)

1. Allen DG, Cairns SP, Turvey SE, et al. Intracellular calcium and myocardial function during ischemia. Adv Exp Ned Biol. 1993;346:19-29.
2. + exchange inhibitor and its effects in cardiac ischemia. Br J Pharmacol. 1993;109:562-568.
3. Ver Donck L, Marcel B, Verdonck F. Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc Res. 1993;27:349-357.
4. 2+ exchange. Circ Res. 1989;65:1045-1056.
5. 2+ exchange inhibitor, KB-R7943, shows renal protective effects in rats with ischemic acute renal failure. J Pharmacol Exp Ther. 2001;296:412-419.
6. 2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury. Eur J Pharmacol. 2003;478;187-198.
7. +-ATPase and suppression of NHE-3. Kidney Int. 1997;51:1106-1115.
8. Bonventre JV. Mechanisms of ischemic renal failure. Kidney Int. 1993;43:1160-1178.
9. Shibouta Y, Suzuki N, Shino A, et al. Pathophysiological role of endothelin in acute renal failure. Life Sci. 1990;46:1611-1618.
10. Wilhelm SM, Simonson MS, Robinson AV, et al. Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int. 1999;55:1011-1018.
11. Firth JD, Ratcliffe PJ. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest. 1992;90:1023-1031.
12. Kuro T, Kohnou K, Kobayashi Y, et al. Selective antagonism of ETA but not ETB receptor is protective against ischemic acute renal failure in rats. Jpn J Pharmacol. 2000;82:307-316.
13. 2+ exchange inhibitor, protects against ischemic acute renal failure in mice by inhibiting renal endothelin-1 overproduction. J Cardiovasc Pharmacol. 2003;42:419-427.
14. 2+ exchanger. J Pharmacol Exp Ther. 2003;304:284-293.
15. Caramelo C, Espinosa G, Manzarbeitia F, et al. Role of endothelium-related mechanisms in the pathophysiology of renal ischemia/reperfusion in normal rabbits. Circ Res. 1996;79:1031-1038.
16. Fujita K, Matsumura Y, Miyazaki Y, et al. Role of endothelin-1 and ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br J Pharmacol. 1995;114:925-930.
17. Matsumura Y, Ikegawa R, Takaoka M, et al. Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cells. Biochem Biophys Res Commun. 1990;167:203-210.
18. Hropot M, Juretschke HP, Langer KH, et al. S3226, a novel NHE3 inhibitor, attenuates ischemia-induced acute renal failure in rats. Kidney Int. 2001;60:2283-2289.
19. + exchanger supports proximal tubular protein reabsorption in vivo. Am J Physiol. 2004;287:F469-473.
20. Choi JY, Shah M, Lee MG, et al. Novel amiloride-sensitive sodium-dependent proton secretion in the mouse proximal convoluted tubule. J Clin Invest. 2000;105:1141-1146.
21. + exchanger. Eur J Med Chem. 2003;38:547-554.
22. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029-1042.
23. 87Rb NMR spectroscopic study. Magn Reson Med. 1995;34:673-685.
24. + exchange. Circ Res. 1990;66:1156-1159.
25. Matsumura Y, Hisaki K, Takaoka M, et al. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Eur J Pharmacol. 1990;185:103-106.
26. Vemulapalli S, Chiu PJ, Chintala M, et al. Attenuation of ischemic acute renal failure by phosphoramidon in rats. Pharmacology. 1993;47:3188-3193.
27. Bird JE, Webb ML, Wasserman AJ, et al. Comparison of a novel ETA receptor antagonist and phosphoramidon in renal ischemia. Pharmacology. 1995;50:9-23.